Bankole A. Johnson
Equibles does not estimate personal net worth.
About Bankole A. Johnson
Azora Therapeutics, Inc. (DE) reported in an 8-K filed April 26, 2024 that Bankole A. Johnson was terminated as Consultant, effective May 17, 2024. Azora Therapeutics, Inc. (DE) reported in an 8-K filed April 16, 2024 that Bankole A. Johnson was terminated as Chief Medical Officer, effective May 17, 2024. The proxy statement of Azora Therapeutics, Inc. (DE) reports total compensation of $435,000 for Bankole A. Johnson in fiscal 2023, including a base salary of $435,000. Disclosed compensation is on record for 4 fiscal years.
“the Company has provided Consultant with written notice of the termination of the Consulting Agreement, effective May 17, 2024 (the "Termination Date")”
“As a result of the termination of the Consulting Agreement, effective as of May 17, 2024, Dr. Johnson will no longer serve as the Company's Chief Medical Officer.”
Affiliation history
-
Azora Therapeutics, Inc. (DE) (AZR)
Proxy statement
Start not stated–2024-05-17
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Azora Therapeutics, Inc. (DE) (AZR) | Former Chief Medical Officer | $435,000 | $435,000 |
| 2022 | Azora Therapeutics, Inc. (DE) (AZR) | Former Chief Medical Officer | $416,200 | $489,422 |
| 2020 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Medical Officer | $375,000 | $375,000 |
| 2019 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Medical Officer | $271,673 | $1,109,580 |